sb 203580 has been researched along with niclosamide in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (niclosamide) | Trials (niclosamide) | Recent Studies (post-2010) (niclosamide) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 979 | 19 | 465 |
| Protein | Taxonomy | sb 203580 (IC50) | niclosamide (IC50) |
|---|---|---|---|
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 13.7 | |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | 10 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.28 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 10 | |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | 0.23 | |
| Anoctamin-1 | Homo sapiens (human) | 0.028 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
1 other study(ies) available for sb 203580 and niclosamide
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |